Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene

被引:151
作者
Silence, J [1 ]
Collen, D [1 ]
Lijnen, HR [1 ]
机构
[1] Catholic Univ Louvain, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium
关键词
matrix metalloproteinases; tissue inhibitor of metalloproteinase-1; apolipoprotein E; atherosclerosis; aneurysm;
D O I
10.1161/01.RES.0000016501.56641.83
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Development and progression of atherosclerotic lesions and aneurysm formation were investigated in mice with single or combined deficiency of apolipoprotein E (ApoE) and tissue inhibitor of metalloproteinase-1 (TIMP-1) kept on a cholesterol -rich diet for 30 weeks. Atherosclerotic lesions throughout the thoracic aorta were significantly (P<0.001) larger in mice wild-type for TIMP-1 (ApoE(-/-):TIMP-1(-/-)) than in mice deficient in TIMP-1 (ApoE(-/-):TIMP-1(-/-)). Aneurysms in the thoracic and abdominal aortas were less frequent in ApoE(-/-):TIMP-1(+/+) mice than in ApoE(-/-):TIMP-1 1(-/-) mice (11+/-3.0 versus 23+/-5.1 aneurysms per 100 sections analyzed, mean+/-SD, P<0.001). Immunocytochemistry revealed enhanced accumulation of Oil red O-stained lipids, colocalizing with macrophages in atherosclerotic lesions of ApoE(-/-):TIMP-1(-/-) mice (P<0.05). In situ zymography using a casein substrate showed enhanced lysis in plaques of ApoE(-/-):TIMP-1(-/-) mice as compared with ApoE(-/-):TIMP-1(+/+) mice (P<0.01). MMP activity was most pronounced at sites where degradation of the elastic lamina occurred. These data suggest that enhanced MNIP activity, as a result of TIMP-1 deficiency, contributes to a reduction of atherosclerotic plaque size but prornotes aneurysm formation.
引用
收藏
页码:897 / 903
页数:7
相关论文
共 36 条
[1]   Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model [J].
Allaire, E ;
Forough, R ;
Clowes, W ;
Starcher, B ;
Clowes, AW .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1413-1420
[2]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[3]   Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Baes, M ;
Lemaitre, V ;
Tipping, P ;
Drew, A ;
Eeckhout, Y ;
Shapiro, S ;
Lupu, F ;
Collen, D .
NATURE GENETICS, 1997, 17 (04) :439-444
[4]  
DAVIES MJ, 1993, BRIT HEART J, V69, P377
[5]  
DECLERCK PJ, 1995, THROMB HAEMOSTASIS, V74, P1305
[6]   MATRIX METALLOPROTEINASES AND CARDIOVASCULAR-DISEASE [J].
DOLLERY, CM ;
MCEWAN, JR ;
HENNEY, AM .
CIRCULATION RESEARCH, 1995, 77 (05) :863-868
[7]   Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells - A potential protective mechanism in plaque stability [J].
Fabunmi, RP ;
Sukhova, GK ;
Sugiyama, S ;
Libby, P .
CIRCULATION RESEARCH, 1998, 83 (03) :270-278
[8]  
GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501
[9]   MICROSCOPIC LOCALIZATION OF ACTIVE PROTEASES BY IN-SITU ZYMOGRAPHY - DETECTION OF MATRIX METALLOPROTEINASE ACTIVITY IN VASCULAR TISSUE [J].
GALIS, ZS ;
SUKHOVA, GK ;
LIBBY, P .
FASEB JOURNAL, 1995, 9 (10) :974-980
[10]   MACROPHAGE FOAM CELLS FROM EXPERIMENTAL ATHEROMA CONSTITUTIVELY PRODUCE MATRIX-DEGRADING PROTEINASES [J].
GALIS, ZS ;
SUKHOVA, GK ;
KRANZHOFER, R ;
CLARK, S ;
LIBBY, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :402-406